Xeomin
MERZ PHARMS · incobotulinumtoxinA
Open FDA's page for this record- Application number
- BLA125360
- Sponsor name
- MERZ PHARMS
- Submissions
- Submission type
- SUPPL
- Submission number
- 66
- Submission status
- AP
- Submission status date
- 20151120
- Submission class code
- MANUF (CMC)
- Submission class code description
- Manufacturing (CMC)
- Application docs
- ID
- 18887
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125360s066lbl.pdf
- Date
- 20151125
- Type
- Label
- Submission type
- SUPPL
- Submission number
- 99
- Submission status
- AP
- Submission status date
- 20240705
- Review priority
- STANDARD
- Submission class code
- EFFICACY
- Submission class code description
- Efficacy
- Submission type
- SUPPL
- Submission number
- 107
- Submission status
- AP
- Submission status date
- 20260320
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 85523
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/125360Orig1s107lbl.pdf
- Date
- 20260325
- Type
- Label
- ID
- 85524
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/125360Orig1s107ltr.pdf
- Date
- 20260325
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 97
- Submission status
- AP
- Submission status date
- 20230908
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 75386
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/125360Orig1s097ltr.pdf
- Date
- 20230911
- Type
- Letter
- ID
- 75447
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125360s097lbl.pdf
- Date
- 20230913
- Type
- Label
- Submission type
- SUPPL
- Submission number
- 89
- Submission status
- AP
- Submission status date
- 20210419
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 67121
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf
- Date
- 20210420
- Type
- Label
- ID
- 67128
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s087, s088, s089, s090, s091ltr.pdf
- Date
- 20210422
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 87
- Submission status
- AP
- Submission status date
- 20210419
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 67119
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf
- Date
- 20210420
- Type
- Label
- ID
- 67126
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s087, s088, s089, s090, s091ltr.pdf
- Date
- 20210422
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 40
- Submission status
- AP
- Submission status date
- 20120716
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 9721
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/125360Orig1s040ltr.pdf
- Date
- 20120718
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 93
- Submission status
- AP
- Submission status date
- 20210813
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 68374
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s093ltr.pdf
- Date
- 20210816
- Type
- Letter
- ID
- 68393
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s093lbl.pdf
- Date
- 20210817
- Type
- Label
- Submission type
- SUPPL
- Submission number
- 91
- Submission status
- AP
- Submission status date
- 20210419
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Application docs
- ID
- 67123
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf
- Date
- 20210420
- Type
- Label
- ID
- 67130
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s087, s088, s089, s090, s091ltr.pdf
- Date
- 20210422
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 7
- Submission status
- AP
- Submission status date
- 20110720
- Review priority
- STANDARD
- Submission class code
- EFFICACY
- Submission class code description
- Efficacy
- Application docs
- ID
- 18885
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125360s007lbl.pdf
- Date
- 20110725
- Type
- Label
- Submission type
- SUPPL
- Submission number
- 67
- Submission status
- AP
- Submission status date
- 20151222
- Review priority
- STANDARD
- Submission class code
- EFFICACY
- Submission class code description
- Efficacy
- Application docs
- ID
- 39938
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125360s067lbl.pdf
- Date
- 20151228
- Type
- Label
- ID
- 31941
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/125360Orig1s067ltr.pdf
- Date
- 20151229
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 73
- Submission status
- AP
- Submission status date
- 20180703
- Review priority
- PRIORITY
- Submission class code
- EFFICACY
- Submission class code description
- Efficacy
- Application docs
- ID
- 54742
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125360s073lbl.pdf
- Date
- 20180703
- Type
- Label
- ID
- 54782
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/125360Orig1s073ltr.pdf
- Date
- 20180706
- Type
- Letter
- +13 more not shown
- Products
- Product number
- 003
- Reference drug
- No
- Brand name
- Xeomin
- Reference standard
- No
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Active ingredients
- Name
- incobotulinumtoxinA
- Strength
- 200 UNITS/VIAL
- Product number
- 001
- Reference drug
- No
- Brand name
- Xeomin
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Active ingredients
- Name
- incobotulinumtoxinA
- Strength
- 50 UNITS/VIAL
- Product number
- 002
- Reference drug
- No
- Brand name
- Xeomin
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Active ingredients
- Name
- incobotulinumtoxinA
- Strength
- 100 UNITS/VIAL
- Harmonized identifiers (openFDA)
- Application number
- BLA125360
- Brand name
- XEOMIN
- Generic name
- INCOBOTULINUMTOXINA
- Manufacturer name
- Merz Pharmaceuticals, LLC, Merz North America, Inc.
- Product NDC
- 0259-1605, 0259-1610, 0259-4150, 0259-4110, 0259-1620, 46783-160, 46783-161, 46783-165
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAMUSCULAR
- Substance name
- BOTULINUM TOXIN TYPE A
- RxCUI
- 1000107, 1009456, 1009459, 1732157, 1732161, 1732165
- SPL ID
- 75c52aa4-0780-4e18-bac3-ba1440a74dee, 8b2d961a-6bb4-4bef-ac07-7dcc2bbfacc7
- SPL set ID
- ccdc3aae-6e2d-4cd0-a51c-8375bfee9458, 3f35d6e0-3450-4abc-a0da-cc7b277e7c6e
- Package NDC
- 0259-1605-01, 0259-1610-01, 0259-4150-01, 0259-4110-01, 0259-1620-01, 0259-1620-10, 46783-161-01, 46783-160-01, 46783-160-10, 46783-165-01
- Nui
- N0000175771, N0000193962, N0000175731, N0000175770
- Pharm class epc
- Acetylcholine Release Inhibitor [EPC], Neuromuscular Blocker [EPC]
- Pharm class pe
- Neuromuscular Blockade [PE]
- Pharm class moa
- Acetylcholine Release Inhibitors [MoA]
- UNII
- E211KPY694
